Meteora Capital, LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-08 2:48 pm Purchase |
2023-08-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Meteora Capital, LLC | 61,286 14.850% |
61,286 (New Position) |
Filing |